ARCHIVES

NCI Natural Product Drug Development To Get New Emphasis; Suggestions Of Critic Accepted

This article is from The Cancer Letter archive.

Vol. 02 No. 12 | March 19, 1976

Download PDF Visit The Full Archive

Related Articles

Two-Point Rise In PSA Signals High-Risk Prostate Cancer

August 26, 2005

Pretreatment with Azacitidine Achieves 28-Month Remission

August 30, 2013

1981 Budget By Funding Mechanism

June 1, 1979

Reinventing NCI: Clinical Trials System Changes Not Easy Or Quick, Klausner Says; NCAB Members, Others, Sound Off On Group’s Report

October 10, 1997

In Brief: Bishop Named Interim Chairman of NCAB; AACI Elects Wicha president, Herberman VP

December 12, 1997

In Brief: More Money For Fewer Grants? Or Spread It Around, Rhoads Asks; AACR To Take Stands

June 10, 1977